TY - JOUR
T1 - A preliminary investigation on the effect of extracorporeal shock wave therapy as a treatment for neurogenic heterotopic ossification following traumatic brain injury. Part II: Effects on function
AU - Reznik, Jacqueline
AU - Biros, Erik
AU - Sacher, Y
AU - Kibrik, O
AU - Milanese, Steve
AU - Gordon, Susan
AU - Galea, Mary
PY - 2017
Y1 - 2017
N2 - Introduction: Neurogenic heterotopic ossification (NHO) occurs as a complication of traumatic brain injury (TBI). Management of clinically significant NHO remains variable. Complications of mature NHO include limitation of mobility. The effect of the extracorporeal shock wave therapy (ESWT) on range of motion at hip and knee, and function in patients with TBI with chronic NHO was investigated. Methods: A series of single-case studies applying ESWT to chronic NHO at the hip or knee of 11 patients with TBI were undertaken at a rehabilitation hospital. Participants received four applications of high-energy EWST delivered to the affected hip or knee over a period of 8 weeks. Two-weekly follow- up assessments were carried out; final assessments were made 3 and 6 months post-intervention. Range of motion (ROM) and Functional Reach (FR) or Modified Functional Reach (MFR) were measured. Results: Application of high-energy ESWT was associated with significant improvement in ROM (flexion) of the NHO-affected knee (Tau = 0.833, 95% CI 0.391–1.276, p = 0.002) and significant improvement of FR (Overall Tau 0.486, 95% CI 0.141–0.832, p = 0.006); no significant improvement in hip ROM or MFR. Conclusions: ESWT may improve mobility and balance of patients with TBI who have chronic NHO.
AB - Introduction: Neurogenic heterotopic ossification (NHO) occurs as a complication of traumatic brain injury (TBI). Management of clinically significant NHO remains variable. Complications of mature NHO include limitation of mobility. The effect of the extracorporeal shock wave therapy (ESWT) on range of motion at hip and knee, and function in patients with TBI with chronic NHO was investigated. Methods: A series of single-case studies applying ESWT to chronic NHO at the hip or knee of 11 patients with TBI were undertaken at a rehabilitation hospital. Participants received four applications of high-energy EWST delivered to the affected hip or knee over a period of 8 weeks. Two-weekly follow- up assessments were carried out; final assessments were made 3 and 6 months post-intervention. Range of motion (ROM) and Functional Reach (FR) or Modified Functional Reach (MFR) were measured. Results: Application of high-energy ESWT was associated with significant improvement in ROM (flexion) of the NHO-affected knee (Tau = 0.833, 95% CI 0.391–1.276, p = 0.002) and significant improvement of FR (Overall Tau 0.486, 95% CI 0.141–0.832, p = 0.006); no significant improvement in hip ROM or MFR. Conclusions: ESWT may improve mobility and balance of patients with TBI who have chronic NHO.
KW - Extracorporeal shock wave therapy
KW - neurogenic heterotopic ossification
KW - Traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=85015981677&partnerID=8YFLogxK
U2 - 10.1080/02699052.2017.1283060
DO - 10.1080/02699052.2017.1283060
M3 - Article
SN - 0269-9052
VL - 31
SP - 533
EP - 541
JO - Brain Injury
JF - Brain Injury
IS - 4
ER -